These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8233249)

  • 1. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
    Wafelman AR; Hoefnagel CA; Beijnen JH
    Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
    Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
    Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
    Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
    Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
    Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
    Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [131I]metaiodobenzylguanidine treatment of a malignant paraganglioma.
    Baulieu JL; Guilloteau D; Calais G; Lefloch O; Besnard JC
    J Nucl Biol Med (1991); 1991; 35(4):313-4. PubMed ID: 1823844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
    Gaze MN; Mairs RJ; Boyack SM; Wheldon TE; Barrett A
    Br J Cancer; 1992 Dec; 66(6):1048-52. PubMed ID: 1457344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.
    Wafelman AR; Nortier YL; Rosing H; Maessen HJ; Taal BG; Hoefnagel CA; Maes RA; Beijnen JH
    Nucl Med Commun; 1995 Sep; 16(9):767-72. PubMed ID: 7478409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
    Sisson JC; Shapiro B; Hutchinson RJ; Carey JE; Zasadny KR; Zempel SA; Normolle DP
    Eur J Nucl Med; 1994 Jan; 21(1):46-52. PubMed ID: 8088285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
    Pujol P; Bringer J; Faurous P; Jaffiol C
    Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.
    Khafagi FA; Shapiro B; Fischer M; Sisson JC; Hutchinson R; Beierwaltes WH
    Eur J Nucl Med; 1991; 18(3):191-8. PubMed ID: 1645665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
    Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
    Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
    J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    J Nucl Med; 1987 Mar; 28(3):308-14. PubMed ID: 3102701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary, conclusions, and future directions of [131I]metaiodobenzylguanidine therapy in the treatment of neural crest tumors.
    Shapiro B
    J Nucl Biol Med (1991); 1991; 35(4):357-63. PubMed ID: 1823858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.